 |
David V. Goeddel, Ph.D.
|
Executive Chairman
|
| John K. Celebi, MBA |
Chief Business Officer |
| Guoqing Chen, Ph.D. |
VP of Research |
| Paul W. Sauer, MBA |
VP of Process Development |
 |
David V. Goeddel, Ph.D.
|
Executive Chairman |
| John D. Diekman, Ph.D. |
| Carl L. Gordon, Ph.D., CFA |
| Robert Schreiber, Ph.D. |
 |
Robert Schreiber, Ph.D.
|
Chairman |
| Rudolf Aebersold, Ph.D. |
|
| Frederick Appelbaum, M.D. |
|
| Thomas Kipps, M.D., Ph.D. |
|
| Richard Klausner, M.D. |
|
| Jeffrey V. Ravetch, M.D., Ph.D. |
|
| Richard Ulevitch, Ph.D. |
|
| Emil Unanue, M.D. |
|
| |
| |
| |
|
|
 |
Dr. Ulevitch is a former Professor and Chairman of the Department of Immunology at The Scripps Research Institute. He is a renowned expert in the field of immunology, and for nearly three decades has performed research to understand the role of the immune system in human disease. He is currently a Venture Partner at 5AM Ventures and Chairman Emeritus at The Scripps Research Institute. Dr. Ulevitch received an A.B. from Washington and Jefferson College and a Ph.D. in Biochemistry from the University of Pennsylvania. |
|
